Please Give us Your Valued Feed Back to Serve you Better Edition #9, 15th july 2011                                                                                   For Browser View:   Click Here Featured Article Ranbaxy, Gilead Sciences to manufacture and market three anti-HIV drugs in India, developing nations       Ranbaxy Laboratories Limited (Ranbaxy) announced today that it has entered into an in-licensing agreement with Gilead Sciences, Inc. for three new HIV/AIDS drugs which are currently in late-stage clinical development.      Ranbaxy will have the rights to produce and sell generic versions of these drugs, under license, in India and other developing nations, after gaining necessary regulatory approvals.       As per the arrangement, Ranbaxy will extend its existing relationship with Gilead for anti-retrovirals and have the rights to manufacture and market generic equivalents of new products, Elvitegravir, an investigational integrase inhibitor, Cobicistat, an investigational antiretroviral boosting agent and Quad, which combines four Gilead HIV medicines in a once-daily, single-tablet regimen. Ranbaxy will receive complete technology transfer of the Gilead manufacturing process and will pay a royalty on sale of finished products.     Source :- Click here Herbal remedy beats brain cancer       More than 100 million Americans - or one-third of the population - suffer from at least one skin disease, and these range from acne to psoriasis and from melanoma to infections, says the report, from the Pharmaceutical Research and Manufacturers of America (PhRMA). Lilly launches weekly diabetes therapy       Anthrax, septicemia and meningitis are some of the planet's most lethal infections. Now a chemist has uncovered the mechanism behind these deadly infections. Ranbaxy recalls skin care drug from UK       Findings from a large-scale study published in The Lancet show that the number of people worldwide with diabetes has more than doubled since 1980. Majid Ezzati, from the UK's School of Public Health at Imperial College London, who led the study along with Goodarz Danaei from the Harvard School of Public Health Nepal becoming dangerous destination for Indian businessmen   A new study has shown that a class of compounds called nitric oxide donors delays the entry of toxins from potentially deadly snakebites. Once-a-day painkiller launched in India           In a major development, the Hyderabad-based multi super speciality hospital, Krishna Institute of Medical Sciences (KIMS), is all set to perform the first robotic assisted surgeries in south India. Dr Reddy Laboratories receives USFDA for DVT         The Tamil Nadu State Medical Council has asked the government to repeal the amendment to the rule under the Drugs and Cosmetics Act, which enabled practitioners of traditional medicine to prescribe allopathic drugs. India plans foreign pharma investment curbs, more price controls        The mystery disease in Bihar's Muzaffarpur district continues to claim more lives with the death toll now touching 44. Over the last 10 days, over 40 children have died due to this unknown virus. Aetna acquires Indian Health Organisation       Aetna International's entry in India, the company recently acquired Indian Health Organization Pvt Ltd. (IHO), an Indian start-up that offers access to quality medical and dental care at a savings through a credentialed provider network. Coming soon: Sunglasses that can change colour rapidly!        A method for creating quick-changing, variable colours in films and displays, such as sunglasses, that could lead to the next hot fashion accessory has been perfected by a University of Connecticut scientist.   Facebook and Skype to team up for video chat function      Social networking site Facebook is reportedly planning to team up with Skype to launch a video chat function for its millions of users. Final News of the World issue costs 30 pounds on eBay      The “historic” final edition of the News of the World - that was published for the last time Sunday - now reportedly costs up to 30 pounds on auction site eBay. Mumbai terror attacks: 17 dead, severed head found       Mumbai woke to a rainy morning in the aftermath of its first terror attack since 26/11. And was back at work - office-goers filling buses and local trains, children off to school. Copyright@  www.nationalpharmamachinery.com . In This Issue Global @ Podium Herbal remedy beats brain cancer Lilly launches weekly diabetes therapy   Ranbaxy recalls skin care drug from UK Nepal becoming dangerous destination for Indian businessmen Indian @ Podium  Once-a-day painkiller launched in India    Dr Reddy Laboratories receives USFDA for DVT India plans foreign pharma investment curbs, more price controls Aetna acquires Indian Health Organisation Also @ Podium Coming soon: Sunglasses that can change colour rapidly! Facebook and Skype to team up for video chat function Final News of the World issue costs 30 pounds on eBay Mumbai terror attacks: 17 dead, severed head found Events @ Podium 17th -29th Sept. , 2011 Venue:-  Gujarat University Hall, Ahmedabad  Details:- Click Here 25th  -27th Oct, 2011 Venue:-  Frankfurt, Germany Details:- Click Here 25th  -27th Oct, 2011 Venue:-  Frankfurt, Germany Details:- Click Here 30th Nov -2nd Dec, 2011 Venue:-  Mumbai, India Details:- Click Here 30th Nov -2nd Dec, 2011 Venue:-  Bombay Exhibition Center Details:- Click Here To unsubscribe:  click here

Please Give us Your Valued Feed Back to Serve you Better Edition #8, 1st july 2011                                                         For Browser View:   Click Here Featured Article Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax       Emergent BioSolutions Inc. (NYSE:EBS) announced today that the Singapore Health Sciences Authority (HSA) has approved Emergent’s product license application for the marketing and sale of BioThrax® (Anthrax Vaccine Adsorbed) in Singapore. BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration (FDA) to protect against anthrax infection.       Emergent is pleased with this development as it continues to grow its presence in the Pacific Rim,” said Daniel J. Abdun-Nabi, president and chief operating officer of Emergent BioSolutions. “With HSA approval of BioThrax, we look forward to initiating discussions with the government of Singapore, as well as other allied governments that recognize HSA registered products such as Brunei, to help protect their constituents against the threat of anthrax as a biological weapon.     Source :- Click here US pharma's 277 drugs in R&D for skin diseases       More than 100 million Americans - or one-third of the population - suffer from at least one skin disease, and these range from acne to psoriasis and from melanoma to infections, says the report, from the Pharmaceutical Research and Manufacturers of America (PhRMA). Chemist solves riddle of killer anthrax, meningitis       Anthrax, septicemia and meningitis are some of the planet's most lethal infections. Now a chemist has uncovered the mechanism behind these deadly infections. Global cases of diabetes climb to 347 million: study       Findings from a large-scale study published in The Lancet show that the number of people worldwide with diabetes has more than doubled since 1980. Majid Ezzati, from the UK's School of Public Health at Imperial College London, who led the study along with Goodarz Danaei from the Harvard School of Public Health New drug containing nitric oxide boosts snakebite survival time   A new study has shown that a class of compounds called nitric oxide donors delays the entry of toxins from potentially deadly snakebites. KIMS to perform south India’s first robot assisted surgeries soon           In a major development, the Hyderabad-based multi super speciality hospital, Krishna Institute of Medical Sciences (KIMS), is all set to perform the first robotic assisted surgeries in south India. Medical council wants Drugs Act repealed        The Tamil Nadu State Medical Council has asked the government to repeal the amendment to the rule under the Drugs and Cosmetics Act, which enabled practitioners of traditional medicine to prescribe allopathic drugs. Mystery disease in Muzaffarpur continues to baffle doctors, toll rises to 44        The mystery disease in Bihar's Muzaffarpur district continues to claim more lives with the death toll now touching 44. Over the last 10 days, over 40 children have died due to this unknown virus. REMI to launch new blood products in market with Barkey       REMI Group has made a formal announcement declaring its decision to make a foray in the segment of critical care equipment range in domestic market. The company has sealed an agreement with Barkey and would be acting as the local distributor and marketing partner for Barkey’s products. Scientists reveal HIV weakness        Vaccines that target newly identified viral protein sequences could be more effective than previous efforts   India, UAE to step up investments      A day after foreign minister-level talks, India Tuesday said it has decided to step up two-way investments in the United Arab Emirates (UAE) and work towards enhancing the profile of their business relations, particularly in the infrastructure sector. ‘Double Dhamaal’ earns big in North America      Bollywood’s new all-star comedy ‘Double Dhamaal’ has opened at number 18 on North American box office charts with a weekend gross of $301,831 despite only playing in 54 theatres across the US States and Canada. Toyota's Rs 3.99L Etios Liva to take on Swift, i10       Japanese auto giant Toyota on Monday drove in Etios Liva compact at Rs 3.99 lakh (ex-showroom Delhi, entry-level model) to mark its presence in the high-volume small car segment in India Copyright@  www.nationalpharmamachinery.com . In This Issue Global @ Podium US pharma's 277 drugs in R&D for skin diseases Chemist solves riddle of killer anthrax, meningitis   Global cases of diabetes climb to 347 million: study New drug containing nitric oxide boosts snakebite survival time Indian @ Podium  KIMS to perform south India’s first robot assisted surgeries soon    Medical council wants Drugs Act repealed Mystery disease in Muzaffarpur continues to baffle doctors, toll rises to 44 REMI to launch new blood products in market with Barkey Also @ Podium Scientists reveal HIV weakness India, UAE to step up investments ‘Double Dhamaal’ earns big in North America Toyota's Rs 3.99L Etios Liva to take on Swift, i10 Events @ Podium 1st to 4th July, 2011 Venue:-  HITEX Exhibition Center, Hyderabad, India Visit us at Stall:- 1.59  Details:- Click Here 17th -29th Sept. , 2011 Venue:-  Gujarat University Hall, Ahmedabad  Details:- Click Here 30th Nov -2nd Dec, 2011 Venue:-  Bombay Exhibition Center Details:- Click Here To unsubscribe:  click here